Section Arrow
LIVN.NASDAQ
- LivaNova PLC
  suspend
Quotes are at least 15-min delayed:2026/04/29 02:34 EDT
Regular Hours
Last
 61.29
-2.12 (-3.34%)
Day High 
63.755 
Prev. Close
63.41 
1-M High
68.04 
Volume 
907.94K 
Bid
48.77
Ask
69.5
Day Low
60.48 
Open
63.63 
1-M Low
60.35 
Market Cap 
3.47B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 65.05 
20-SMA 64.31 
50-SMA 64.71 
52-W High 71.92 
52-W Low 35 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.45/4.56
Enterprise Value
3.86B
Balance Sheet
Book Value Per Share
21.94
Cash Flow
Cash Flow Yield
0.07
Income Statement
Total Revenue
1.39B
Operating Revenue Per Share
20.45
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
PFSAProfusa Inc.0.5553+0.0422+8.22%-- 
BSXBoston Scientific Corp58.45-1.5-2.50%30.9PE
ABTAbbott Laboratories93.86+1.06+1.14%24.95PE
MDTMedtronic plc81.9-1.02-1.23%23.16PE
ZBHZimmer Biomet Holdings82.8-9.79-10.57%26.08PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.